Personalized Medicine At Stake In Prometheus Patent Case, BIO Tells Supreme Court

The biotech and pharmaceutical industries oppose a broad ruling that would prevent patenting of medical processes and diagnostics. Mayo is challenging patents on the correlation between drug metabolites and proper dosage.

More from Legal & IP

More from Pink Sheet